(EXI1) iShares SLI (DE) - Ratings and Ratios
Swiss Stocks, Large Cap Stocks, Equity Funds
Description: EXI1 iShares SLI (DE)
The iShares SLI UCITS ETF (DE) is an exchange-traded fund listed on XETRA under the ticker symbol EXI1, tracking the Morningstar Switzerland TME NR CHF index. As a Switzerland Equity ETF, it provides investors with exposure to the Swiss equity market.
With Assets Under Management (AUM) of approximately €463.23 million, the ETF has a considerable presence in the market. To evaluate its performance, key metrics such as tracking error, expense ratio, and liquidity should be considered. A low tracking error would indicate that the ETF is effectively mirroring the performance of its underlying index. The expense ratio, which is not provided, is another crucial KPI as it directly impacts investor returns. Liquidity, measured by average trading volume and bid-ask spread, is also vital for investors to enter or exit positions efficiently.
From a technical analysis perspective, the ETFs price action relative to its moving averages (SMA20, SMA50, SMA200) suggests a potential trend. The last price of €146.76 being above the SMA20 and slightly below the SMA50 indicates a possible short-term consolidation. The Average True Range (ATR) of 1.12, representing a 0.76% daily price range, implies relatively moderate volatility. To further assess the ETFs attractiveness, investors should consider its historical returns, Sharpe ratio, and beta relative to the broader market.
To make an informed investment decision, its essential to evaluate the ETFs underlying index, the Morningstar Switzerland TME NR CHF. This includes analyzing the indexs composition, sector allocation, and market capitalization distribution. Understanding the indexs methodology and rebalancing frequency is also crucial. By doing so, investors can better comprehend the ETFs potential risks and opportunities, aligning it with their overall investment strategy.
Additional Sources for EXI1 ETF
EXI1 ETF Overview
Market Cap in USD | 541m |
Category | Switzerland Equity |
IPO / Inception | 2001-03-22 |
EXI1 ETF Ratings
Growth Rating | 62.8 |
Fundamental | - |
Dividend Rating | 52.3 |
Rel. Strength | -17.7 |
Analysts | - |
Fair Price Momentum | 142.34 EUR |
Fair Price DCF | - |
EXI1 Dividends
Dividend Yield 12m | 1.38% |
Yield on Cost 5y | 2.15% |
Annual Growth 5y | 8.58% |
Payout Consistency | 90.0% |
Payout Ratio | % |
EXI1 Growth Ratios
Growth Correlation 3m | 15.1% |
Growth Correlation 12m | 50.6% |
Growth Correlation 5y | 85.8% |
CAGR 5y | 9.20% |
CAGR/Max DD 5y | 0.45 |
Sharpe Ratio 12m | 1.06 |
Alpha | -3.38 |
Beta | 0.571 |
Volatility | 10.27% |
Current Volume | 1.2k |
Average Volume 20d | 1.3k |
Stop Loss | 142.5 (-3%) |
As of July 16, 2025, the stock is trading at EUR 146.94 with a total of 1,198 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +0.64%, over three months by +5.19% and over the past year by +5.98%.
Yes. Based on ValueRay's Analyses, iShares SLI (DE) (XETRA:EXI1) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.80 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EXI1 is around 142.34 EUR . This means that EXI1 is currently overvalued and has a potential downside of -3.13%.
iShares SLI (DE) has no consensus analysts rating.
According to our own proprietary Forecast Model, EXI1 iShares SLI (DE) will be worth about 159.4 in July 2026. The stock is currently trading at 146.94. This means that the stock has a potential upside of +8.5%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 159.4 | 8.5% |